2m 2m 2m 2m 2m 2m 2m
Item 9 Labs (INLB)
OTC
$0.000001$0.00 (0.00%)
Price as of May 28, 2026- $102.00Market Cap
- 0.00%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Item 9 Labs (INLB)
$0.000001$0.00 (0.00%)
INLB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.00 | ||
Change | $0.00 (0.00%) | ||
Open | $0.00 | ||
High | $0.00 | ||
Low | $0.00 | ||
Previous Close | $0.00 | ||
Volume | 200,000 | ||
30-Day Average Volume | 110,685 | ||
1-Week Change | 0.00% | ||
1-Month Change | 0.00% | ||
1-Year Change | 0.00% | ||
3-Year Change | -100.00% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 102.4M | ||
Total Assets | $112.0M | ||
Market Cap | $102.00 | ||
Enterprise Value | $72.0M | ||
Period: QTR TTM FY | |||
Revenue | $5.0M | ||
Net Income | -$5.9M | ||
Free Cash Flow | $87,292.00 | ||
EBIT | -$3.0M | ||
EBITDA | -$2.7M | ||
Net Working Capital | -$55.5M | ||
EPS | -$0.06 | ||
Enterprise Value/EBITDA | -27 | ||
Enterprise Value/Revenue | 14 | ||
P/B | 0 | ||
P/E | -0 | ||
PEG | 0 | ||
Price/Free Cash Flow | 0 | ||
Price/Operating Cash Flow | 0 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 10/18/2018 | ||